Genetic Testing, Insurance Economics, and Societal Responsibility

DOI10.1080/10920277.1999.10595764MaRDI QIDQ5718331zbMATH OpenOpenAlexFDO

Authors Patrick L. Brockett, Maureen Carter, Richard D. MacMinn

Publication date 13 January 2006

Published in North American Actuarial Journal (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1080/10920277.1999.10595764

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Applications of statistics to actuarial sciences and financial mathematics (62P05)

Recommendations

• Social Implications of Genetic Testing
• The Current State of Genetic Testing
• The Future of Risk Classification in the Age of Predictive DNA-Based Testing
• What Does Genetic Technology Have to Do with Ethics?
• Federal Regulation of Use of Genetic Information by Insurers

Cited in

(12)

• Genetics, Alzheimer’s Disease, and Long-Term Care Insurance
• Effective Underwriting in the Genetic Testing Era
• Ethical Issues Resulting from Genetic Technology
• Federal Regulation of Use of Genetic Information by Insurers
• Restricting Insurers’ Use of Genetic Information
• Social Implications of Genetic Testing
• The Future of Risk Classification in the Age of Predictive DNA-Based Testing
• The Current State of Genetic Testing
• What Does Genetic Technology Have to Do with Ethics?
• A simulation study for multifactorial genetic disorders to quantify the impact of polygenic risk scores on critical illness insurance
• Genetics and Insurance: What have we Learned So Far?
• Optimal risk classification with an application to substandard annuities

This page was built for publication: Genetic Testing, Insurance Economics, and Societal Responsibility

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5718331)